Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration.
There is growing evidence that thrombotic and inflammatory pathways contribute to the severity of COVID-19. Common medications such as aspirin, that mitigate these pathways, may decrease COVID-19 mortality. This retrospective assessment was designed to quantify the correlation between pre-diagnosis...
Main Authors: | Thomas F Osborne, Zachary P Veigulis, David M Arreola, Satish M Mahajan, Eliane Röösli, Catherine M Curtin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0246825 |
Similar Items
-
Automated EHR score to predict COVID-19 outcomes at US Department of Veterans Affairs.
by: Thomas F Osborne, et al.
Published: (2020-01-01) -
Effect of Immersive Virtual Reality on Pain and Anxiety at a Veterans Affairs Health Care Facility
by: Caitlin R. Rawlins, et al.
Published: (2021-10-01) -
Aspirin in COVID-19: Pros and Cons
by: Al Saleh, T., et al.
Published: (2022) -
Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates
by: Januar Wibawa Martha, et al.
Published: (2021-07-01) -
The Decline in Hydrocodone/Acetaminophen Prescriptions in Emergency Departments in the Veterans Health Administration Between 2009 to 2015
by: Michael A. Grasso, et al.
Published: (2016-06-01)